Delta Variant Might be Responsible for 86% of COVID Cases Among Vaccinated Indians

Delta variant of SARS-CoV-2 is considered to be highly transmissible in nature. A new ICMR study found that around 86% of the vaccinated Indians developed COVID-19 only due to this variant during the recent second wave of the pandemic.

Around 86% of vaccinated people who got Covid-19 were infected by the Delta variant of SARS-CoV-2. Researchers from ICMR have reported this finding based on a new study that observed the incidence of COVID-19 among Indians.

The study monitored 677 covid-19 patients, of which 71 got the Covaxin, 604 got the Covishield, and 2 had Sinopharm vaccine. The subjects were from states and Union Territories.

Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.

With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.

‘Among 677 vaccinated individuals, 71% developed symptomatic COVID-19, while 29% had an asymptomatic infection. Only about 0.4% of the infected ones died.’

Researchers collected throat and nasal swabs from the patients and used genomic analyses to characterize the cases. In addition to this, the symptoms of the patients were also recorded.

Based on the findings, they reported that

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

• Around 71% of the cases were symptomatic, and 29% were asymptomatic

• The widely prevalent symptoms were fever (69%), body ache, headache and nausea (56%), cough (45%), sore throat (37%), loss of smell and taste (22%), diarrhea (6%), breathing issues (6%), and eye-related disorders (1%)

�Super Vaccine� To Fight Against SARS-CoV-2 Mutants
A new super-vaccine of mRNA origin that could fight against SARS-CoV-2 mutants is likely to begin human trials next year.

The study also reported that only 0.4% of the infected persons died due to COVID-19. It is important to note that both Covaxin and Covishield are effective against the delta variant, according to the statement of the Health Ministry.

Source-Medindia

Second Wave of COVID-19 Witnesses More Deadly Strain Than Ever
Newly mutated A.P. strain of covid-19 spikes up the second wave.The shorter incubation period of newly mutated N440K variants of COVID-19 is shown to spike up the “second wave” of COVID-19.